Skip to main content
main-content
Erschienen in: Der Urologe 4/2022

06.04.2022 | Prostatakarzinom | CME

Multiparametrische MRT der Prostata

verfasst von: Judith Herrmann, Prof. Dr. med. Sascha Kaufmann, Cecilia Zhang, Steffen Rausch, Jens Bedke, Arnulf Stenzl, Konstantin Nikolaou, Stephan Kruck, Ferdinand Seith

Erschienen in: Der Urologe | Ausgabe 4/2022

zum CME-Kurs Einloggen, um Zugang zu erhalten

Zusammenfassung

Die multiparametrische Magnetresonanztomographie (mpMRT) ist fester Bestandteil der Prostatakarzinomdiagnostik. Sie soll gemäß der S3-Leitlinie „Prostatakarzinom“ zur Primärdiagnostik sowie in der aktiven Überwachung eingesetzt werden. Die mpMRT beinhaltet hochauflösende T2-gewichtete (T2w) Sequenzen, diffusionsgewichtete („diffusion-weighted imaging“, DWI) und dynamische kontrastmittelgestützte Sequenzen (DCE), welche Grundlage für die Befundung gemäß der PI-RADS(Prostate Imaging Reporting and Data System)-Klassifikation sind.
Zugang erhalten Sie mit:
e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76(3):340–351 CrossRef Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76(3):340–351 CrossRef
2.
Zurück zum Zitat Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261(1):46–66 CrossRef Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261(1):46–66 CrossRef
3.
Zurück zum Zitat Gerharz EW, Heidenreich A (2021) Aktualisierte S3-Leitlinie Prostatakarzinom. Uro-News 25(9):18–23 CrossRef Gerharz EW, Heidenreich A (2021) Aktualisierte S3-Leitlinie Prostatakarzinom. Uro-News 25(9):18–23 CrossRef
4.
Zurück zum Zitat Franiel T, Asbach P, Beyersdorff D et al (2021) mpMRI of the prostate (MR-prostatography): updated recommendations of the DRG and BDR on patient preparation and scanning protocol. Rofo 193(7):763–777 PubMed Franiel T, Asbach P, Beyersdorff D et al (2021) mpMRI of the prostate (MR-prostatography): updated recommendations of the DRG and BDR on patient preparation and scanning protocol. Rofo 193(7):763–777 PubMed
5.
Zurück zum Zitat Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822 CrossRef Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822 CrossRef
6.
Zurück zum Zitat van der Leest M, Cornel E, Israel B et al (2019) Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naive men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol 75(4):570–578 CrossRef van der Leest M, Cornel E, Israel B et al (2019) Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naive men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol 75(4):570–578 CrossRef
7.
Zurück zum Zitat Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378(19):1767–1777 CrossRef Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378(19):1767–1777 CrossRef
8.
Zurück zum Zitat Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65(1):124–137 CrossRef Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65(1):124–137 CrossRef
9.
Zurück zum Zitat Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1):61–71 CrossRef Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1):61–71 CrossRef
10.
Zurück zum Zitat Cornford P, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol 79(2):263–282 CrossRef Cornford P, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol 79(2):263–282 CrossRef
11.
Zurück zum Zitat Lai WS, Gordetsky JB, Thomas JV et al (2017) Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population. Cancer 123(11):1941–1948 CrossRef Lai WS, Gordetsky JB, Thomas JV et al (2017) Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population. Cancer 123(11):1941–1948 CrossRef
12.
Zurück zum Zitat Distler FA, Radtke JP, Bonekamp D et al (2017) The value of PSA density in combination with PI-RADS for the accuracy of prostate cancer prediction. J Urol 198(3):575–582 CrossRef Distler FA, Radtke JP, Bonekamp D et al (2017) The value of PSA density in combination with PI-RADS for the accuracy of prostate cancer prediction. J Urol 198(3):575–582 CrossRef
13.
Zurück zum Zitat Tsai LL, Grant AK, Mortele KJ et al (2015) A practical guide to MR imaging safety: what radiologists need to know. Radiographics 35(6):1722–1737 CrossRef Tsai LL, Grant AK, Mortele KJ et al (2015) A practical guide to MR imaging safety: what radiologists need to know. Radiographics 35(6):1722–1737 CrossRef
14.
Zurück zum Zitat Slough RA, Caglic I, Hansen NL et al (2018) Effect of hyoscine butylbromide on prostate multiparametric MRI anatomical and functional image quality. Clin Radiol 73(2):216.e9–e14 CrossRef Slough RA, Caglic I, Hansen NL et al (2018) Effect of hyoscine butylbromide on prostate multiparametric MRI anatomical and functional image quality. Clin Radiol 73(2):216.e9–e14 CrossRef
15.
Zurück zum Zitat Ullrich T, Quentin M, Schmaltz AK et al (2018) Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate. Eur Radiol 28(1):17–23 CrossRef Ullrich T, Quentin M, Schmaltz AK et al (2018) Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate. Eur Radiol 28(1):17–23 CrossRef
16.
Zurück zum Zitat Franiel T, Quentin M, Mueller-Lisse UG et al (2017) MRI of the prostate: recommendations on patient preparation and scanning protocol. Rofo 189(1):21–28 PubMed Franiel T, Quentin M, Mueller-Lisse UG et al (2017) MRI of the prostate: recommendations on patient preparation and scanning protocol. Rofo 189(1):21–28 PubMed
17.
Zurück zum Zitat Mai J, Abubrig M, Lehmann T et al (2019) T2 mapping in prostate cancer. Invest Radiol 54(3):146–152 CrossRef Mai J, Abubrig M, Lehmann T et al (2019) T2 mapping in prostate cancer. Invest Radiol 54(3):146–152 CrossRef
18.
Zurück zum Zitat Schick F, Pieper CC, Kupczyk P et al (2021) 1.5 vs 3 tesla magnetic resonance imaging: a review of favorite clinical applications for both field strengths-part 1. Invest Radiol 56(11):680–691 CrossRef Schick F, Pieper CC, Kupczyk P et al (2021) 1.5 vs 3 tesla magnetic resonance imaging: a review of favorite clinical applications for both field strengths-part 1. Invest Radiol 56(11):680–691 CrossRef
19.
Zurück zum Zitat Tirumani SH, Suh CH, Kim KW et al (2020) Head-to-head comparison of prostate MRI using an endorectal coil versus a non-endorectal coil: meta-analysis of diagnostic performance in staging T3 prostate cancer. Clin Radiol 75(2):157.e9–e19 CrossRef Tirumani SH, Suh CH, Kim KW et al (2020) Head-to-head comparison of prostate MRI using an endorectal coil versus a non-endorectal coil: meta-analysis of diagnostic performance in staging T3 prostate cancer. Clin Radiol 75(2):157.e9–e19 CrossRef
20.
Zurück zum Zitat Mirak SA, Shakeri S, Bajgiran AM et al (2019) Three tesla multiparametric magnetic resonance imaging: comparison of performance with and without endorectal coil for prostate cancer detection, PI-RADS version 2 category and staging with whole mount histopathology correlation. J Urol 201(3):496–502 CrossRef Mirak SA, Shakeri S, Bajgiran AM et al (2019) Three tesla multiparametric magnetic resonance imaging: comparison of performance with and without endorectal coil for prostate cancer detection, PI-RADS version 2 category and staging with whole mount histopathology correlation. J Urol 201(3):496–502 CrossRef
21.
Zurück zum Zitat Chen J, Liu RB, Tan P (2014) The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis. Eur Radiol 24(8):1929–1941 CrossRef Chen J, Liu RB, Tan P (2014) The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis. Eur Radiol 24(8):1929–1941 CrossRef
22.
Zurück zum Zitat Mueller-Lisse UG, Mueller-Lisse UL, Zamecnik P et al (2011) Diffusion-weighted MRI of the prostate. Radiologe 51(3):205–214 CrossRef Mueller-Lisse UG, Mueller-Lisse UL, Zamecnik P et al (2011) Diffusion-weighted MRI of the prostate. Radiologe 51(3):205–214 CrossRef
23.
Zurück zum Zitat Quentin M, Schimmoller L, Arsov C et al (2014) Increased signal intensity of prostate lesions on high b‑value diffusion-weighted images as a predictive sign of malignancy. Eur Radiol 24(1):209–213 CrossRef Quentin M, Schimmoller L, Arsov C et al (2014) Increased signal intensity of prostate lesions on high b‑value diffusion-weighted images as a predictive sign of malignancy. Eur Radiol 24(1):209–213 CrossRef
25.
Zurück zum Zitat Hricak H, Dooms GC, McNeal JE et al (1987) MR imaging of the prostate gland: normal anatomy. AJR Am J Roentgenol 148(1):51–58 CrossRef Hricak H, Dooms GC, McNeal JE et al (1987) MR imaging of the prostate gland: normal anatomy. AJR Am J Roentgenol 148(1):51–58 CrossRef
26.
Zurück zum Zitat Oto A, Kayhan A, Jiang Y et al (2010) Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 257(3):715–723 CrossRef Oto A, Kayhan A, Jiang Y et al (2010) Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 257(3):715–723 CrossRef
27.
Zurück zum Zitat Sciarra A, Panebianco V, Salciccia S et al (2011) Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci. Urol Oncol 29(6):634–640 CrossRef Sciarra A, Panebianco V, Salciccia S et al (2011) Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci. Urol Oncol 29(6):634–640 CrossRef
28.
Zurück zum Zitat Kitzing YX, Prando A, Varol C et al (2016) Benign conditions that mimic prostate carcinoma: MR imaging features with histopathologic correlation. Radiographics 36(1):162–175 CrossRef Kitzing YX, Prando A, Varol C et al (2016) Benign conditions that mimic prostate carcinoma: MR imaging features with histopathologic correlation. Radiographics 36(1):162–175 CrossRef
29.
Zurück zum Zitat Panebianco V, Giganti F, Kitzing YX et al (2018) An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines. Insights Imaging 9(1):87–101 CrossRef Panebianco V, Giganti F, Kitzing YX et al (2018) An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines. Insights Imaging 9(1):87–101 CrossRef
30.
Zurück zum Zitat Rosenkrantz AB, Taneja SS (2014) Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol 202(1):109–120 CrossRef Rosenkrantz AB, Taneja SS (2014) Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol 202(1):109–120 CrossRef
31.
Zurück zum Zitat Vargas HA, Akin O, Franiel T et al (2012) Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications. Radiology 262(3):894–902 CrossRef Vargas HA, Akin O, Franiel T et al (2012) Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications. Radiology 262(3):894–902 CrossRef
32.
Zurück zum Zitat Cohen RJ, Shannon BA, Phillips M et al (2008) Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features. J Urol 179(5):1762–1767 (discussion 7) CrossRef Cohen RJ, Shannon BA, Phillips M et al (2008) Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features. J Urol 179(5):1762–1767 (discussion 7) CrossRef
33.
Zurück zum Zitat Tamada T, Sone T, Jo Y et al (2008) Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 248(2):531–539 CrossRef Tamada T, Sone T, Jo Y et al (2008) Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 248(2):531–539 CrossRef
Metadaten
Titel
Multiparametrische MRT der Prostata
verfasst von
Judith Herrmann
Prof. Dr. med. Sascha Kaufmann
Cecilia Zhang
Steffen Rausch
Jens Bedke
Arnulf Stenzl
Konstantin Nikolaou
Stephan Kruck
Ferdinand Seith
Publikationsdatum
06.04.2022